Aigen Investment Management, LP Legend Biotech Corp Transaction History
Aigen Investment Management, LP
- $533 Million
- Q4 2024
A detailed history of Aigen Investment Management, LP transactions in Legend Biotech Corp stock. As of the latest transaction made, Aigen Investment Management, LP holds 7,363 shares of LEGN stock, worth $264,110. This represents 0.04% of its overall portfolio holdings.
Number of Shares
7,363
Previous 6,157
19.59%
Holding current value
$264,110
Previous $300,000
20.33%
% of portfolio
0.04%
Previous 0.06%
Shares
6 transactions
Others Institutions Holding LEGN
# of Institutions
229Shares Held
78.4MCall Options Held
229KPut Options Held
372K-
Price T Rowe Associates Inc Baltimore, MD11.2MShares$401 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.51MShares$269 Million5.1% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.64MShares$238 Million7.41% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$205 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.71MShares$205 Million0.86% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $6B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...